From Wikipedia, the free encyclopedia
Morphinan-based opioid
Oxymorphone-3-methoxynaltrexonazine
(7Z)-7-[(Z)-[3-(cyclopropylmethyl)-4a-hydroxy-9-methoxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ylidene]hydrazinylidene]-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol
CAS Number
PubChem
CID
ChemSpider
UNII
Formula C 38 H 44 N 4 O 6
Molar mass 652.792 g·mol−1 3D model (
JSmol )
CN1CCC23C4C(=NN=C5CCC6(C7CC8=C9C6(C5OC9=C(C=C8)OC)CCN7CC5CC5)O)CCC2(C1CC1=C3C(=C(C=C1)O)O4)O
InChI=1S/C38H44N4O6/c1-41-15-13-35-29-21-5-7-25(43)31(29)47-33(35)23(9-11-37(35,44)27(41)17-21)39-40-24-10-12-38(45)28-18-22-6-8-26(46-2)32-30(22)36(38,34(24)48-32)14-16-42(28)19-20-3-4-20/h5-8,20,27-28,33-34,43-45H,3-4,9-19H2,1-2H3/b39-23-,40-24-
Key:ORPKJVOXWSMNDJ-XCKRHRGHSA-N
Oxymorphone-3-methoxynaltrexonazine (OM-3-MNZ ) is a
morphinan -based
opioid that acts as a selective
μ-opioid receptor agonist, unlike the closely related mixed agonist-antagonist Oxymorphonenaltrexonazine.
[1]
See also
References